EUVIMEDEUVIMED entdecken
Crossref

Formulation, Optimisation and Evaluation of Metformin Hydrochloride Sustained-Release Matrix Tablets Using Hydroxypropyl Di-Starch Phosphate

Arvind Kumar, Nita Yadav, Ritesh Kumar Tiwari, Mayank Patel, Aditi Gupta

International Journal of Drug Delivery Technology · 03.06.2026 · 16 (45s)

DOI: 10.25258/ijddt.16.45s.42 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Drug Delivery Technology, online erschienen am 03.06.2026. Verfasst von Arvind Kumar und 4 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Metformin hydrochloride (HCl) is the first-line oral pharmacotherapy for Type 2 Diabetes Mellitus (T2DM); however, its high daily dose (500–2500 mg), short biological half-life (4–6 h) and frequent gastrointestinal side effects compromise patient compliance. The present work describes the formulation, statistical optimisation and evaluation of a 12-h sustained-release (SR) matrix tablet of metformin HCl using hydroxypropyl di-starch phosphate (HPDSP) - a chemically modified type-4 resistant starch (RS4) - in combination with hydroxypropyl methylcellulose (HPMC K-100). Nine batches (F1–F9) were prepared by direct compression following a 3² full factorial design varying HPDSP (100, 150, 200 mg) and HPMC K-100 (100, 125, 150 mg). All powder blends exhibited good flow (Carr's Index 11.98–12.20%, Hausner ratio 1.136–1.139, angle of repose 28.4°–29.3°). Compressed tablets met pharmacopoeial limits for hardness (5.1–5.6 kg/cm²), friability (

Zitieren

APA

Kumar, A., Yadav, N., Tiwari, R. K., Patel, M., & Gupta, A. (2026). Formulation, Optimisation and Evaluation of Metformin Hydrochloride Sustained-Release Matrix Tablets Using Hydroxypropyl Di-Starch Phosphate. International Journal of Drug Delivery Technology, 16(45s). https://doi.org/10.25258/ijddt.16.45s.42

Vancouver

Kumar A, Yadav N, Tiwari RK, Patel M, Gupta A. Formulation, Optimisation and Evaluation of Metformin Hydrochloride Sustained-Release Matrix Tablets Using Hydroxypropyl Di-Starch Phosphate. International Journal of Drug Delivery Technology. 2026;16(45s). doi:10.25258/ijddt.16.45s.42

BibTeX
@article{Kumar2026,
  author = {Kumar, Arvind and Yadav, Nita and Tiwari, Ritesh Kumar and Patel, Mayank and Gupta, Aditi},
  title = {Formulation, Optimisation and Evaluation of Metformin Hydrochloride Sustained-Release Matrix Tablets Using Hydroxypropyl Di-Starch Phosphate},
  journal = {International Journal of Drug Delivery Technology},
  year = {2026},
  volume = {16},
  number = {45s},
  doi = {10.25258/ijddt.16.45s.42}
}
Kostenlos starten →